Evidence map›Paper›PMID 33115478›Full record

ArticleBMC public health2020

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.

Nicholas Musinguzi, Lara Kidoguchi, Nelly R Mugo, Kenneth Ngure, Elly Katabira, Connie L Celum, Jared M Baeten, Renee Heffron, Jessica E Haberer, Partners Demonstration Project Team

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men: A Systematic Review and Meta-analysis.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Nicholas MusinguziGlobal Health Collaborative, Mbarara University of Science and Technology, P. O Box 434, Mbarara, Uganda. nmusinguzi@gmail.com.ORCID http://orcid.org/0000-0002-1269-4623
Lara KidoguchiDepartment of Medicine, University of Washington, Seattle, USA.
Nelly R MugoCentres for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kenneth NgureSchool of Public Health, Jomo Kenyatta University of Agriculture and Technology Nairobi, Nairobi, Kenya.
Elly KatabiraInfectious Disease Institute, Makerere University, Kampala, Uganda.
Connie L CelumDepartment of Medicine, University of Washington, Seattle, USA.
Jared M BaetenDepartment of Medicine, University of Washington, Seattle, USA.
Renee HeffronDepartment of Global Health, University of Washington, Seattle, USA.
Jessica E HabererMassachusetts General Hospital and Harvard Medical School, Boston, USA.
Partners Demonstration Project Team
University of Washington · USHarvard University · USMbarara University of Science and Technology · UGJomo Kenyatta University of Agriculture and Technology · KE

Funding

Optimizing Antiretroviral-Based HIV Prevention for HIV Serodiscordant CouplesR01MH095507 · NIMH · UNIVERSITY OF WASHINGTON · PI BAETEN, JARED · 2011 to 2020
$6.1M
Real World Adherence to HIV PrEP in Serodiscordant African CouplesR01MH098744 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2013 to 2017
$3.0M
Optimizing mHealth for adherence monitoring and interventionK24MH114732 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2017 to 2021
$800k
Bill and Melinda Gates Foundation OPP1056051National Institute of Mental Health (US) R01MH095507NIMH NIH HHS K24 MH114732NIMH NIH HHS R01 MH095507NIMH NIH HHS R01 MH098744NIMH NIH HHS R01MH098744Office of International Science and Engineering (US) AID-OAA-A-12-00023
6 · The paper itself

Abstract

backgroundPrEP use should be aligned with periods of risk for HIV acquisition. For HIV serodiscordant couples, PrEP can be used as a bridge until the partner living with HIV takes antiretroviral therapy (ART) long enough to achieve viral suppression (the "PrEP as a Bridge to ART" strategy). However, adherence to this strategy is unknown.

methodsIn a demonstration project in Kenya and Uganda, HIV-uninfected partners of serodiscordant couples were advised to take PrEP until the partner living with HIV took ART for ≥ 6 months. PrEP discontinuation was then recommended unless there were concerns about ART adherence, immediate fertility intentions, or outside partners with unknown HIV/ART status. Electronic adherence monitoring and socio-behavioral questionnaire data were used in logistic regression models to explore completion of this strategy and continuation of PrEP beyond recommendations to stop its use.

resultsAmong 833 serodiscordant couples, 436 (52%) HIV-uninfected partners completed ≥ 6 months of PrEP as a bridge to ART. Strategy completion was associated with older age (aOR per 5 years = 1.1; p = 0.008) and having fewer children (aOR = 0.9; p = 0.019). Of the 230 participants encouraged to stop PrEP according to strategy recommendations, 170 (74%) did so. PrEP continuation among the remaining 60 participants was associated with more education (aOR = 1.1; p = 0.029), a preference for PrEP over ART (aOR = 3.6; p = 0.026), comfort with managing their serodiscordant relationship (aOR = 0.6; p = 0.046), and believing PrEP makes sex safe (aOR = 0.5; p = 0.026).

conclusionHalf of participants completed the PrEP as a bridge to ART strategy and the majority stopped PrEP as recommended. These findings suggest that targeting PrEP to periods of risk is a promising approach; however, tailoring counseling around aligning PrEP use and HIV risk will be important for optimal strategy implementation.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAgedChildHumansKenyaSexual PartnersUgandaAnti-HIV AgentsAdherenceARTDemonstration projectKenyaPrEPUganda

Identifiers

PMID33115478
PMCPMC7594426
OpenAlexW3094974306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.